Contributor: Special thanks to Rogério Teixeira and Lino Gonçalves from European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Based on the 2013 ESC guidelines on the management of stable coronary artery disease
Webinar: Current management of stable coronary artery disease. Diagnosis, medical treatment and options for revascularization Watch the recording.
Part 1 - Overview of the 2013 ESC guideline on the management of stable coronary artery disease
| Session |
Presentation Title |
Slides |
Webcast |
| New 2013 ESC Guidelines on stable coronary artery disease |
Stable coronary artery disease beyond flow-limiting stenoses. |
|
|
| Diagnosis and prognosis of stable coronary artery disease. |
|
|
| Drugs in stable coronary artery disease |
|
|
| From optimal medical therapy to revascularisation |
|
|
| Take home message for practitioners |
Coronary artery disease update 2013 |
|
|
| FOCUS Imaging and intervention: Angina pectoris stable |
Risk stratification in patient with stable angina. Imaging techniques and risk stratification. Insights from 2013 ESC Guidelines. |
|
|
| Asymptomatic patient with stroke and cardiovascular risk factors. Do we need further cardiac evaluation of this high risk population? |
|
|
Part 2 - Topics in focus
| Topic |
Presentation Title |
Slides |
Webcast |
Imaging
|
Perfusion or anatomy imaging. Do we need both? |
|
|
| Nuclear perfusion imaging and cardiac computed tomography |
|
|
| Combined wall motion and myocardial perfusion imaging by cardiac magnetic resonance. |
|
|
| Coronary Angiography |
Assessing fractional flow reserve in patients with microvascular dysfunction |
|
|
| Proven ischaemia and non-obstructive coronary artery disease |
|
|
| Assessing the microcirculation in dysfunctional myocardium after myocardial infarction. |
|
|
| Use of coronary angiography in patients with stable ischaemic heart disease |
|
|
| |
Meet the expert: Non-intervention versus intervention in stable angina |
Revascularization |
Ischaemia as the gatekeeper. |
|
|
| The cath lab identifies and solves the problem. |
|
|
| Non-intervention versus intervention in stable angina - Take home message & what do the guidelines say? |
|
|
| Fractional flow reserve-guided percutaneous coronary intervention versus medical therapy for stable coronary disease: a definitive trial? |
|
|
| Left main stem stenosis: insights from SYNTAX to EXCEL. |
|
|
| 5-year follow-up from SYNTAX trial: the messages. |
|
|
| Certainties and controversies |
|
|
| ASCERT: comparative efficacy or not in real world three-vessel coronary artery disease? |
|
|
| No more FREEDOM of choice. |
|
|
| SYNTAX - making simple sense out of the complexities of multivessel coronary artery disease. |
|
|
| Fractional flow reserve and all that FAME: what's significant in coronary artery disease? |
|
|
| Revascularisation options in diabetic patients: updates from FREEDOM. |
|
|
| Comparative effectiveness of revascularisation strategies. |
|
|
| Risk scores: should I bother? |
|
|
| Completeness of revascularisation: in whom does it matter? |
|
|
| FREEDOM and the future. |
|
|
| Putting it all together - past, present and future. |
|
|
| Novel and emerging therapies for managing the patient with advanced coronary artery disease. |
|
|
| Myocardial revascularisation in patients with diabetes - coronary artery bypass grafting or percutaneous coronary intervention? |
|
|
| Miscellaneous |
Management of cardiovascular disease in diabetes |
|
|
| Multifocal atherosclerosis in patients with coronary artery disease |
| Should we look for it and how? |
|
|
| Should they be treated differently? |
|
|
| An algorithm for invasive treatment in a poly-vascular patient. |
|
|
| Positron emission tomography/computed tomography and molecular imaging for multifocal atherosclerosis: luxury or necessity? |
|
|
Our mission: To reduce the burden of cardiovascular disease.